These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19035252)

  • 1. [Present status of studies on the treatment of choroidal neovascularization by Anecortave acetate].
    Li X; Wang YS
    Zhonghua Yan Ke Za Zhi; 2008 Jun; 44(6):571-4. PubMed ID: 19035252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical efficacy of anecortave acetate.
    Clark AF
    Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S41-8. PubMed ID: 17240256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes.
    Russell SR; Hudson HL; Jerdan JA;
    Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S79-90. PubMed ID: 17240260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anecortave acetate for treating or preventing choroidal neovascularization.
    Slakter JS
    Ophthalmol Clin North Am; 2006 Sep; 19(3):373-80. PubMed ID: 16935212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anecortave acetate.
    Clarke MS
    Ophthalmology; 2004 Dec; 111(12):2316; author reply 2316-7. PubMed ID: 15582099
    [No Abstract]   [Full Text] [Related]  

  • 6. Anecortave acetate for fibrotic lesions with presence of residual peripheral activity in age-related macular degeneration.
    Aggermann T; Haas P; Binder S
    Ann Ophthalmol (Skokie); 2008; 40(1):28-30. PubMed ID: 18556978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Schmidt-Erfurth U; Michels S; Michels R; Aue A
    Eur J Ophthalmol; 2005; 15(4):482-5. PubMed ID: 16001382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anecortave may help choroidal neovascularization regression in serpiginous choroiditis.
    Nóbrega MJ; Rosa EL; Belfort R; Farah ME
    Can J Ophthalmol; 2007 Feb; 42(1):151-2. PubMed ID: 17361268
    [No Abstract]   [Full Text] [Related]  

  • 9. First clinical experience with anecortave acetate (Retaane).
    Hayek S; Scherrer M; Barthelmes D; Fleischhauer JC; Kurz-Levin MM; Menghini M; Helbig H; Sutter FK
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):279-81. PubMed ID: 17458792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis.
    Fine HF; Zhitomirsky I; Freund KB; Barile GR; Shirkey BL; Samson CM; Yannuzzi LA
    Retina; 2009 Jan; 29(1):8-12. PubMed ID: 18784620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of the angiostatic cortisene anecortave acetate.
    Clark AF
    Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S26-34. PubMed ID: 17240253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of changes in choroidal neovascularization secondary to age-related macular degeneration after anti-VEGF therapy using spectral domain optical coherence tomography.
    You JY; Chung H; Kim HC
    Curr Eye Res; 2012 May; 37(5):438-45. PubMed ID: 22510011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.
    Penn JS; Rajaratnam VS; Collier RJ; Clark AF
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):283-90. PubMed ID: 11133880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroidal neovascularization in pathologic myopia: intravitreal ranibizumab versus bevacizumab--a randomized controlled trial.
    Gharbiya M; Giustolisi R; Allievi F; Fantozzi N; Mazzeo L; Scavella V; Gabrieli CB
    Am J Ophthalmol; 2010 Mar; 149(3):458-64.e1. PubMed ID: 20172072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to ocular histoplasmosis syndrome.
    Nielsen JS; Fick TA; Saggau DD; Barnes CH
    Retina; 2012 Mar; 32(3):468-72. PubMed ID: 21817958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study.
    Klais CM; Eandi CM; Ober MD; Sorenson JA; Sadeghi SN; Freund KB; Spaide RF; Slakter JS; Yannuzzi LA
    Retina; 2006 Sep; 26(7):773-9. PubMed ID: 16963850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation.
    Gasperini JL; Fawzi AA; Khondkaryan A; Lam L; Chong LP; Eliott D; Walsh AC; Hwang J; Sadda SR
    Br J Ophthalmol; 2012 Jan; 96(1):14-20. PubMed ID: 21791509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Be cautious to treat choroidal neovascularization with anti-angiogenesis pharmacotherapy].
    Wei WB; Mo J
    Zhonghua Yan Ke Za Zhi; 2008 Mar; 44(3):193-5. PubMed ID: 18785539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroidal neovascularization secondary to Sorsby fundus dystrophy treated with systemic bevacizumab (Avastin).
    Prager F; Michels S; Geitzenauer W; Schmidt-Erfurth U
    Acta Ophthalmol Scand; 2007 Dec; 85(8):904-6. PubMed ID: 17433023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.